Stock Analiz

Cardiff Oncology, Inc. (CRDF) stock forecast and price target

Price $0.73 · data as of November 13, 2026

12-month price target

Average target$6.28
Upside / downside+765.4%
Analysts6
ConsensusBuy
Low $1.20Average $6.28High $12.00

Gold marker: average target · white marker: today’s price ($0.73)

Analyst ratings

Strong buy 1Buy 2Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.56+19.3%$360670
Next fiscal year
ends December 31, 2027
$-0.52+6.1%$320830
Next quarter
ends December 31, 2026
$-0.12−12.1%$48750
Quarter after
ends March 31, 2027
$-0.12+30.6%$87500

Consensus of the analysts covering Cardiff Oncology, updated daily. In the last 30 days 4 estimates were raised and 0 lowered.

Frequently asked questions

What is the Cardiff Oncology stock price target?

The average 12-month target from 6 analysts is $6.28, 765.4% above the current price of $0.73 Targets range from $1.20 to $12.00.

Is Cardiff Oncology a buy according to analysts?

The consensus rating is “Buy” (1 strong buy, 2 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Cardiff Oncology expected to earn?

Analysts expect EPS of $-0.56 for the fiscal year ending December 31, 2026 and $-0.52 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.